Back
Virtus LifeSci Biotech Clinical Trls ETF Vs. Amplify Treatments, Testing and Adv ETF Industry Stock Comparison
Buy
75
BBC
Virtus LifeSci Biotech Clinical Trls ETF
Last Price:
27.33
Seasonality Move:
4.24%
Sell
44
GERM
Amplify Treatments, Testing and Adv ETF
Last Price:
18.33
Seasonality Move:
4.95%
Buy
75
Virtus LifeSci Biotech Clinical Trls ETF (BBC)
is a Buy
Is Virtus LifeSci Biotech Clinical Trls ETF a Buy, Sell or Hold?
- The current Virtus LifeSci Biotech Clinical Trls ETF [BBC] share price is $27.43. The Score for BBC is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- BBC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Amplify Treatments, Testing and Adv ETF (GERM)
is a Sell
Is Amplify Treatments, Testing and Adv ETF a Buy, Sell or Hold?
- The current Amplify Treatments, Testing and Adv ETF [GERM] share price is $18.07. The Score for GERM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- GERM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BBC Stock Price Chart
What is Virtus LifeSci Biotech Clinical Trls ETF's stock price today?
-
The Virtus LifeSci Biotech Clinical Trls ETF share price today is $27.43
The current trend is moderately bullish and BBC is experiencing selling pressure, which indicates risk of future bearish movement.
GERM Stock Price Chart
What is Amplify Treatments, Testing and Adv ETF's stock price today?
-
The Amplify Treatments, Testing and Adv ETF share price today is $18.07
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GERM is experiencing buying pressure, which is a positive indicator for future bullish movement.
BBC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 53.34 | Buy |
Chaikin Money Flow: | -7974 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.55 - 27.71) | Buy |
Bollinger Bands (100): | (24.69 - 29.01) | Buy |
GERM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 57.51 | Buy |
Chaikin Money Flow: | 6517 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.71 - 18.03) | Buy |
Bollinger Bands (100): | (17.53 - 19.13) | Sell |
BBC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.41 | Buy |
20-day SMA: | 26.37 | Buy |
50-day SMA: | 27.95 | Sell |
200-day SMA: | 23.53 | Buy |
8-day EMA: | 27.31 | Buy |
20-day EMA: | 26.99 | Buy |
50-day EMA: | 27.1 | Buy |
200-day EMA: | 25.14 | Buy |
GERM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.03 | Buy |
20-day SMA: | 17.27 | Buy |
50-day SMA: | 17.8 | Buy |
200-day SMA: | 18.19 | Sell |
8-day EMA: | 17.94 | Buy |
20-day EMA: | 17.66 | Buy |
50-day EMA: | 17.77 | Buy |
200-day EMA: | 18.61 | Sell |
Virtus LifeSci Biotech Clinical Trls ETF Earnings Growth & BBC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amplify Treatments, Testing and Adv ETF Earnings Growth & GERM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Virtus LifeSci Biotech Clinical Trls ETF Technical Analysis
Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Amplify Treatments, Testing and Adv ETF Technical Analysis
Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |